Mabini Colleges
COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructo

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
Amlodipinebesylate calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor

COLLEGE OF NURSING AND MIDWIFERY
NAME____________________________________________________________ AGE____________ DIAGNOSIS_________________________________________________
DRUGS ACTION
Generic Name:  Inhibits the movement of
calcium ions across the
membranes of cardiac and
Brand Name: arterial muscle cells;
Norvasc inhibition of transmembrane
calcium flow results in the
Classification: depression of impulse
 Antihypertensive formation in a specialized
 Calcium channel cardiac pacemaker cells, in
blocker slowing the velocity of
 Antianginal conduction of the cardiac
impulse, in the depression of
Dosage: myocardial contractility, and
5g OD in the dilation of coronary
arteries and arterioles and
peripheral arterioles ; these
effects lead to decreased
cardiac work, decreased
cardiac oxygen consumption,
and patients with vasospastic
(Prinzmetals’s) angina,
increase delivery of oxygen
to cardiac cells.
Prepared by:
__________________________________________________
Student Nurse and Signature
Mabini Colleges
Daet, Camarines Norte
DRUG STUDY
INDICATION CONTRAINDICATION ADVERSE EFFECT NURSING CONSIDERATION
 Angina pectoris due  Contraindicated with  CNS: Dizziness, light- Assessment
to coronary artery allergy to amlodipine, headedness, * History: Allergy to amlodipine,
spasm (Prinzmetal’s impaired hepatic or headache, asthenia,fati impaired hepatic or renal function,
variant angina) renal function, sick gue, lethargy sick sinus syndrome, heart block,
 Chronic stable sinus syndrome, heart  CV: Peripheral lactation, CHF
angina, alone or in block (second or third edema, arrhythmias * Physical: Skin lesions, color,
combination with degree), lactation.  Dermatologic: Flushing edema; P, BP, baseline ECG,
other agents  Use cautiously with , rash peripheral perfusion, auscultation;
 Essential CHF, pregnancy.  GI: Nausea, abdominal R, adventitious sounds; liver
hypertension, alone discomfort evaluation, GI normal output; liver
or in combination and renal function tests, urinalysis
with other
antihypertensives Interventions:
Monitor patient carefully (BP, cardiac
rhythm, and output) while adjusting
drug to therapeutic dose; use special
caution if patient has CHF.
 Monitor BP very carefully if patient
is also on nitrates.
 Monitor cardiac rhythm regularly
during stabilization of dosage and
periodically during long-term
therapy.
 Administer drug without regard to
meals.
_______________________________ _____________________________________________
DATE Clinical Instructor
 Mabini Colleges
COLLEGE OF NURSING AND MIDWIFERY
Daet, Camarines Norte